Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients

Pain Physician

Volumn 16, Issue 1, 2013, Pages 9-14

  Duarte, Rui V ^a,b   Raphael, Jon H ^a,b   Labib, Mourad ^b   Southall, Jane L ^b   Ashford, Robert L ^a  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Diagnostic criteria; Free testosterone; Hypogonadism; Implantable drug delivery systems; Total serum testosterone

Indexed keywords

ANDROGEN; BACLOFEN; BUPIVACAINE; CLONIDINE; FOLLITROPIN; LUTEINIZING HORMONE; MORPHINE; OPIATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; HUMAN; HYPOGONADISM; LONG TERM CARE; MALE; NEUROPATHIC PAIN; NOCICEPTION; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

AGED; ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; HYPOGONADISM; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; PREVALENCE; TESTOSTERONE;

EID: 84872818832     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-3672.
2. de Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997; 19:96-112.
3. Biggs SA, Duarte RV, Raphael JH, Ashford RL. Influence of a latent period in QALY analysis: Pilot study of intrathecal drug delivery systems for chronic nonmalignant pain. Br J Neurosurg 2011; 25:401-406.
4. Nordberg G, Hedner T, Mellstrand T, Dahlström B. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984; 60:448-454.
5. Bernards C. Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology 2006; 105:169-178.
6. Winkelmüller M, Winkelmüller W. Longterm effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85:458-467.
7. Doleys D, Dinoff B, Page L, Tutak U, Willis K, Coleton M. Sexual dysfunction and other side effects of intraspinal opiate use in the management of chronic noncancer pain. American Journal of Pain Management 1998; 8:5-11.
8. Reddy RG, Aung T, Karavitaki N, Wass JAH. Opioid induced hypogonadism. BMJ 2010; 341:c4462.
9. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009; 25:170-175.
10. Vuong C, Van Uum SHM, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010; 31:98-132.
11. Raverot V, Lopez J, Grenot C, Pugeat M, Déchaud H. New approach for measurement of non-SHBG-bound tes tosterone in human plasma. Anal Chim Acta 2010; 658:87-90.
12. Vermeulen A. Hormonal cut-offs of partial androgen deficiency: A survey of androgen assays. J Endocrinol Invest 2005; 28:28-31.
13. Hackett GI. Review: Androgens, erectile dysfunction and cardiovascular risk in type 2 diabetes. Br J Diabetes Vasc Dis 2009; 9:214-217.
14. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92:405-413.
15. Kapoor P, Luttrell BM, Williams D. The free androgen index is not valid for adult males. J Steroid Biochem Mol Biol 1993; 45:325-326.
16. Roberts L, Finch P, Pullan P, Bhagat C, Price L. Sex hormone suppression by intrathecal opioids: A prospective study. Clin J Pain 2002; 18:144-148.
17. Hackett G, Cole NS, Deshpande AA, Popple MD, Kennedy D, Wilkinson P. Biochemical hypogonadism in men with type 2 diabetes in primary care practice. Br J Diabetes Vasc Dis 2009; 9:226-231.
18. Harman S, Metter E, Tobin J, Pearson J, Blackman M. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86:724-731.
19. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet V, Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000; 85:2215-2222.
20. Finch P, Roberts L, Price L, Hadlow N, Pullan P. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000; 16:251-254.
21. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002; 3:377-384.
22. Fraser LA, Morrison D, Morley-Forster P, Paul TL, Tokmakejian S, Nicholson LR, Bureau Y, Friedman TC, Van Uum SH. Oral opioids for chronic non-cancer pain: Higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009; 117:38-43.
23. Rajagopal A, Vassilopoulou-Sellin R, Palmer J, Kaur G, Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 2003; 26:1055-1061.
24. Alam F, Duarte R, Raphael J, Labib M, Mutagi H, Kapur S. Low dose intrathecal morphine therapy and hypogonadotrophic hypogonadism. Reg Anesth Pain Med 2008; 33:e202.
25. Monga TN, Tan G, Ostermann HJ, Monga U, Grabois M. Sexuality and sexual adjustment of patients with chronic pain. Disabil Rehabil 1998; 20:317-329.
26. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
27. Haffner SM, Shaten J, Stem MP, Smith GD, Kuller L; MRFIT Research Group. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am J Epidemiol 1996; 143:889-897.
28. Paice JA, Penn RD. Amenorrhea associated with intraspinal morphine. J Pain Symptom Manage 1995; 10:582-583.
29. Daniell HW, Lentz R, Mazer NA. Openlabel pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006; 7:200-210.
30. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992; 13:297-304.
31. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E. Function of the male sex organs in heroin and methadone users. N Engl J Med 1975; 292:882-887.
32. Mendelson JH, Mello NK. Plasma testosterone levels during chronic heroin use and protracted abstinence. A study of Hong Kong addicts. Clin Pharmacol Ther 1975; 17:529-533.
33. Wang C, Chan V, Yeung RT. The effect of heroin addiction on pituitary-testicular function. Clin Endocrinol 1978; 9:455-461.
34. Forman LJ, Tingle V, Estilow S, Cater J. The response to analgesia testing is affected by gonadal steroids in the rat. Life Sci 1989; 45:447-454.
35. Pednekar JR, Mulgaonker VK. Role of testosterone on pain threshold in rats. Indian J Physiol Pharmacol 1995; 39:423-424.